<?xml version="1.0" encoding="UTF-8"?>
<ref id="B33">
 <label>33.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Hershberger</surname>
    <given-names>E</given-names>
   </name>, 
   <name name-style="western">
    <surname>Sloan</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Narayan</surname>
    <given-names>K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Hay</surname>
    <given-names>CA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Smith</surname>
    <given-names>P</given-names>
   </name>, 
   <name name-style="western">
    <surname>Engler</surname>
    <given-names>F</given-names>
   </name>, 
   <name name-style="western">
    <surname>Jeeninga</surname>
    <given-names>R</given-names>
   </name>, 
   <name name-style="western">
    <surname>Smits</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Trevejo</surname>
    <given-names>J</given-names>
   </name>, 
   <name name-style="western">
    <surname>Shriver</surname>
    <given-names>Z</given-names>
   </name>, 
   <name name-style="western">
    <surname>Oldach</surname>
    <given-names>D</given-names>
   </name>
  </person-group>
  <year>2019</year>
  <article-title>Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: results from a randomized, double-blind, phase-2, placebo-controlled study</article-title>. 
  <source>EBioMedicine</source>
  <volume>40</volume>:
  <fpage>574</fpage>â€“
  <lpage>582</lpage>. doi:
  <pub-id pub-id-type="doi">10.1016/j.ebiom.2018.12.051</pub-id>.
  <pub-id pub-id-type="pmid">30638863</pub-id>
 </mixed-citation>
</ref>
